Furthermore, we would argue that NFE2L2/PGC-1α -/- dKO mice display many unique characteristics of clinical dry AMD, and perhaps these animals can be exploited for target discovery and drug validation. This evidence concerns the gene PPARGC1A and dry age related macular degeneration.